The key to the diverse roles of different classes of GSTs is due to their structure, specifically the composition and spatial localization of amino acid residues composed in the enzymatic active sites
IGF-1 LR3 (Insulin-like Growth Factor 1 Long R3) is an 83-amino-acid synthetic variant of human IGF-1, engineered with two key structural modifications: a glutamic acid substitution for arginine at position 3 (R3) and a 13-amino-acid N-terminal extension peptide
Priority should be given to well-designed human intervention studies, integrate systems biology approaches, and explore delivery technologies that enhance the stability and targeted action of these molecules
A potential disadvantage of a more sensitive screening is that it will likely also result in identification of asymptomatic individuals who may never develop clinical symptoms
Conditions like pernicious anaemia (an autoimmune condition affecting a protein called intrinsic factor vital for B12 absorption), stomach issues (such as from reduced stomach acid or certain medications like proton pump inhibitors), intestinal disorders (like Crohns disease or coeliac disease), or even surgical removal of parts of the small intestine (e.g., gastric bypass surgery) can prevent proper absorption